TCRX
#4243
TScan Therapeutics, Inc. - Common Stock
0.9 3 USD
-0.10%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-9.71%
Monthly Change
-1.06%
6 month change
-16.96%
Year Change
-48.04%
Previous Close
1.0 3
Open
0.9 3
Low
0.9 3
High
0.9 3
Volume
8
Financials
- Market Capitalization 56.8 M
- Employee 142
- Founded 2018
- CEO N/A
- Website www.tscan.com
- Headquarter Delaware, United States
- FIGI BBG00PH1N007
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1
Price to sales ratio
12.57
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4240 |  CNTX Context Therapeutics Inc. - Common Stock | 0.62 USD | 0.00% | -10.14% | -11.43% | -19.48% | 56.97 M USD | ||
| 4242 |  INKT MiNK Therapeutics, Inc. - Common Stock | 11.41 USD | +1.60% | +7.54% | -9.16% | +3.73% | 56.84 M USD | ||
| 4250 |  BOLD Boundless Bio, Inc. - Common Stock | 2.46 USD | +0.82% | -0.81% | +72.03% | +112.07% | 55.26 M USD | ||
| 4253 |  BYSI BeyondSpring, Inc. - Ordinary Shares | 1.33 USD | 0.00% | -18.90% | -17.39% | -41.41% | 54.69 M USD |
Frequently asked questions about TScan Therapeutics, Inc. - Common Stock
What is the TScan Therapeutics, Inc. - Common Stock stock price today?
The current price of TScan Therapeutics, Inc. - Common Stock (TCRX) is 0.93. Over the past 24 hours, the stock has changed by -9.71%. Follow the TCRX chart for real-time price dynamics.
What is the stock ticker of TScan Therapeutics, Inc. - Common Stock?
TScan Therapeutics, Inc. - Common Stock trades under the ticker TCRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is TScan Therapeutics, Inc. - Common Stock stock going up?
TCRX has changed by -13.89% over the last week, -1.06% over the last month, and -48.04% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was TScan Therapeutics, Inc. - Common Stock net income for the last quarter?
TScan Therapeutics, Inc. - Common Stock reported net income of -28.67 M for the last quarter. The previous quarter showed -22.98 M, which means net income changed by -24.76%.
How many employees does TScan Therapeutics, Inc. - Common Stock have?
As of the latest available data, TScan Therapeutics, Inc. - Common Stock has 142 employees. Workforce size can provide additional context about the company's scale and operations.
What is TScan Therapeutics, Inc. - Common Stock EBITDA?
TScan Therapeutics, Inc. - Common Stock EBITDA is -28.45 M, and its EBITDA margin is -2 896.74%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy TScan Therapeutics, Inc. - Common Stock stock?
You can buy TScan Therapeutics, Inc. - Common Stock (TCRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in TScan Therapeutics, Inc. - Common Stock stock?
Investing in TScan Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TCRX chart and related analysis on metatrader.com as part of your research.